Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The p12 protein of murine leukemia virus (MuLV) group-specific antigen (Gag) is associated with the preintegration complex, and mutants of p12 (PM14) show defects in nuclear entry or retention. Here we show that p12 proteins engineered to encode peptide sequences derived from known viral tethering proteins can direct chromatin binding during the early phase of viral replication and rescue a lethal p12-PM14 mutant. Peptides studied included segments of Kaposi sarcoma herpesvirus latency-associated nuclear antigen (LANA) 1–23 , human papillomavirus 8 E2, and prototype foamy virus chromatin-binding sequences. Amino acid substitutions in Kaposi sarcoma herpesvirus LANA and prototype foamy virus chromatin-binding sequences that blocked nucleosome association failed to rescue MuLV p12-PM14. Rescue by a larger LANA peptide, LANA 1–32 , required second-site mutations that are predicted to reduce peptide binding affinity to chromosomes, suggesting that excessively high binding affinity interfered with Gag/p12 function. This is supported by confocal microscopy of chimeric p12-GFP fusion constructs showing the reverted proteins had weaker association to condensed mitotic chromosomes. Analysis of the integration-site selection of these chimeric viruses showed no significant change in integration profile compared with wild-type MuLV, suggesting release of the tethered p12 post mitosis, before viral integration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In MLV, the chromatin tethering function is accomplished by p12, a small phosphoprotein that is encoded within the gag gene, which acts in a manner seemingly indistinguishable from the PFV Gag CBS93–95.”
From Structure and function of retroviral integrase (2022) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-citationTranscription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 1×
“In contrast, infection by gammaretroviruses such as murine leukemia virus (MuLV) requires cell division (2), and integration is biased toward transcriptional start sites (3, 4) and CpG islands (3, 5).”
BackgroundRetroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976 · cited 2×
“Proc Natl Acad Sci USA 103(5):1498–1503.”
BackgroundSelf-citationIntegration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921 · cited 1×
“In contrast, infection by gammaretroviruses such as murine leukemia virus (MuLV) requires cell division (2), and integration is biased toward transcriptional start sites (3, 4) and CpG islands (3, 5).”
BackgroundA transient three-plasmid expression system for the production of high titer retroviral vectors
Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M., & Kingsman, A. J. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.4.628 · Cited by 690 · cited 1×
“Cells were then treated with 10 mM Na butyrate for 6 h (36), and the medium was”
MethodAlbritton, L. M., Tseng, L., Scadden, D., & Cunningham, J. M. (1989) · Cell · doi:10.1016/0092-8674(89)90134-7 · Cited by 688 · cited 1×
“In the first, the p12 constructs were engineered into a full-length provirus, and viral replication was measured through multiple rounds of infection in D17 cells rendered permissive for MuLV infection (22).”
MethodHigh-titer packaging cells producing recombinant retroviruses resistant to human serum
Cosset, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A., & Collins, M. K. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7430-7436.1995 · Cited by 661 · cited 1×
“293T cells stably expressing the MuLV Gag-Pol proteins (293T CeB cells) (34) were used to generate virus to transduce the D17 cells with the pGIP vectors (32).”
MethodA role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658 · cited 5×
“Schröder ARW, et al. (2002) HIV-1 integration in the human genome favors active genes and local hotspots.”
MethodSelf-citationDynamic interactions between transposable elements and their hosts
Levin, H. L., & Moran, J. V. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3030 · Cited by 621 · cited 1×
“In addition, lentiviruses, spumaviruses, and retrotransposons (13) all possess mechanisms for tethering viral DNA to host chromatin before integration.”
BackgroundThe Nucleosomal Surface as a Docking Station for Kaposi's Sarcoma Herpesvirus LANA
Barbera, A. J., Chodaparambil, J. V., Kelley-Clarke, B., Joukov, V., Walter, J. C., Luger, K., & Kaye, K. M. (2006) · Science · doi:10.1126/science.1120541 · Cited by 503 · cited 4×
“Similar to KSHV LANA1–23 (17), the PFV CBS is reported to tether to the core nucleosome (16).”
BackgroundInfluential
Cited by
Integration site selection by retroviruses and transposable elements in eukaryotes
Sultana, T., Zamborlini, A., Cristofari, G., & Lesage, P. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.7 · Cited by 275
De Rijck, J., de Kogel, C., Demeulemeester, J., Vets, S., El Ashkar, S., Malani, N., Bushman, F. D., Landuyt, B., Husson, S. J., Busschots, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.040 · Cited by 175
“In conclusion, we propose a model for MLV integration targeting incorporating previous insights on the function of MLV p12 and the newly described MLV IN-BET interaction (Figure S4) (Elis et al., 2012; Schneider et al., 2013).”
MethodSelf-citationMatreyek, K., & Engelman, A. (2013) · Viruses · doi:10.3390/v5102483 · Cited by 145
Molecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
“However, mutations that altered p12 interactions with chromatin had no detectable effects on MoMLV integration target site selection (152).”
BackgroundStructure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Metadata
- Authors
- Schneider, W. M., Brzezinski, J. D., Aiyer, S., Malani, N., Gyuricza, M., Bushman, F. D., & Roth, M. J.
- Affiliations
- University of Medicine and Dentistry of New Jersey (US)
- University of Pennsylvania (US)
- Departments of aBiochemistry and
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-05-09
- Volume
- 110
- Issue
- 23
- Pages
- 9487-9492
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3677494
- OpenAlex
- W2030853182
- Cited by
- 49
- References
- 39
- Citations by year
- 2025: 1 · 2024: 3 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 1 · 2018: 9 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 5
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM070837, GM088808, R01GM088808, T32GM008360)
- National Institute of Allergy and Infectious Diseases (AI52845, R01AI082020, R01AI052845, AI082020)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- murine leukemia virus, preintegration complex, chromatin binding, nuclear entry, integration site selection, viral replication
- MeSH terms
- Animals, Antigens, Viral, Base Sequence, Cell Line, Chromatin, Cloning, Molecular, DNA, Viral, Dogs, Humans, Molecular Sequence Data, Leukemia Virus, Murine, Mutation, Nuclear Proteins, Oncogene Proteins, Viral, Virus Replication, Blotting, Western, Protein Engineering, Trans-Activators, Gene Products, gag, Virus Integration, Sequence Analysis, DNA, Microscopy, Confocal, Fluorescence Recovery After Photobleaching, Immunoprecipitation, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag. https://app.cochat.ai/papers/10.1073/pnas.1221736110
- The paper
- Schneider, W. M., Brzezinski, J. D., Aiyer, S., Malani, N., Gyuricza, M., Bushman, F. D., & Roth, M. J. (2013). Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1221736110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.